Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
BackgroundInsulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) has been reported to exhibit an oncogenic effect as an RNA-binding protein (RBP) by promoting tumor cell proliferation, migration and invasion in several tumor types. However, a pan-cancer analysis of IGF2BP3 is not currently av...
Main Authors: | Pin Chen, Jing Xu, Zihan Cui, Silin Wu, Tao Xie, Xiaobiao Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1071675/full |
Similar Items
-
Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer
by: Hui Deng, et al.
Published: (2024-02-01) -
Pan-cancer analysis identified IGF2BP2 as a potential prognostic biomarker for multiple tumor types
by: Hong-Lu Zhou, et al.
Published: (2024-01-01) -
Parkin regulates IGF2BP3 through ubiquitination in the tumourigenesis of cervical cancer
by: Xin Sun, et al.
Published: (2023-10-01) -
Insights into the role of the N6-methyladenosine reader IGF2BP3 in the progression of oral squamous cell carcinoma and its connection to cell-cycle control
by: Dandan Song, et al.
Published: (2024-06-01) -
IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
by: Wei Huang, et al.
Published: (2023-02-01)